Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_1
4
80%

Phase Distribution

4

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 2Efficacy & side effects
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (80.0%)
Phase 21 (20.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_2

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

NCT00151398
completedphase_1

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

NCT00499642
completedphase_1

Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects

NCT00538889
completedphase_1

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

NCT00494962
completedphase_1

Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects

NCT00366483

Clinical Trials (5)

Showing 5 of 5 trials
NCT00151398Phase 2

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Completed
NCT00499642Phase 1

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

Completed
NCT00538889Phase 1

Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects

Completed
NCT00494962Phase 1

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Completed
NCT00366483Phase 1

Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5